NCT00001851 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Danon M, Crawford JD
The McCune-Albright syndrome. Ergeb Inn Med Kinderheilkd. 1987;55:81-115. Review.
Mastorakos G, Mitsiades NS, Doufas AG, Koutras DA
Hyperthyroidism in McCune-Albright syndrome with a review of thyroid abnormalities sixty years after the first report. Thyroid. 1997 Jun;7(3):433-9.
Mauras N, Blizzard RM
The McCune-Albright syndrome. Acta Endocrinol Suppl (Copenh). 1986;279:207-17.

Evaluation and Treatment to Improve Bone Quality and Prevent Fractures by the Percutaneous Replacement of Diseased Tissue in Polyostotic Fibrous Dysplasia and McCune-Albright Syndrome

Details for clinical trial NCT00001851

Clinical trial NCT00001851 - References